THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS)
$0.17 0.007445 (4.58%)
Analysed THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) News Sources
Light-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy
02-03-2026
yahoo.com
Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer
09-03-2026
yahoo.com
Theralase(R) Closes $1.1 M Non-Brokered Private Placement
10-03-2026
yahoo.com
Theralase(R) Discovers Further Mechanism on How Ruvidar(R) Inactivates Herpes Simplex Virus
17-03-2026
yahoo.com
Theralase(R) Closes $CAN 2.66 Million Financing
10-04-2026
yahoo.com
Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
13-04-2026
yahoo.com
Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
04-05-2026
yahoo.com
Theralase(R) Announces $4 Million Brokered LIFE Offering
05-05-2026
yahoo.com
Theralase(R) Closes C$4.8 Million Offering
20-05-2026
yahoo.com
Theralase(R) Releases Q1 2026 Financial Statements
29-05-2026
yahoo.com
What is the current price of THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS)?
The current price of THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) is $0.17.
THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) since the previous trading day is $0.007445.
THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) since the previous trading day is 4.58%.
What is the most recent average sentiment score for THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS)?
The most recent average sentiment score for THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) is 72 out of 100.
What is the most recent average sentiment for THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS)?
The most recent sentiment for THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) is .
SEC-8K** Filing Available For THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.